Global Transplantation of Hematopoietic Stem Cells 麻豆原创 Research Report 2024

Publication ID:

PB505252008

Publication Date:

May 10, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Over 51 years of studies in the field of blood-forming stem cells i.e. hematopoietic stem cells (HSC), researchers have developed significant understanding to use HSCs as a therapy. At present, no type of stem cell, adult, embryonic or fetal has attained such sufficient status. Hematopoietic stem cell transplantation (HSCT) is now routinely used for treating patients with malignant and non-malignant disorders of blood and the immune system. Currently, researchers have observed that through animal studies HSCs have the ability to form other cells such as blood vessels, muscles, and bone.
The global Transplantation of Hematopoietic Stem Cells market was valued at US$ 1348 million in 2023 and is anticipated to reach US$ 2627.2 million by 2030, witnessing a CAGR of 10.0% during the forecast period 2024-2030.
The Transplantation of Hematopoietic Stem Cells market is primarily driven by its potential to provide curative treatments for various hematological disorders, including leukemia, lymphoma, and certain genetic diseases. Hematopoietic stem cell transplantation (HSCT) involves replacing damaged or malfunctioning bone marrow with healthy stem cells to restore normal blood cell production. The increasing prevalence of hematological diseases, coupled with advancements in transplantation techniques, contributes to market growth. Moreover, the demonstrated benefits of HSCT in achieving long-term remission, improving overall survival rates, and offering a potential cure for patients with limited treatment options further propel adoption. However, challenges include finding suitable donors, addressing potential graft-versus-host disease and other complications, and managing post-transplant care. Navigating patient-donor matching, ensuring graft compatibility, and providing comprehensive patient support are ongoing concerns. The market's success relies on continuous research in transplantation science, collaborations between medical institutions and stem cell banks, and comprehensive education on the benefits and potential challenges of hematopoietic stem cell transplantation while addressing the evolving challenges associated with donor availability and patient outcomes.
This report aims to provide a comprehensive presentation of the global market for Transplantation of Hematopoietic Stem Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transplantation of Hematopoietic Stem Cells.
Report Scope
The Transplantation of Hematopoietic Stem Cells market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Transplantation of Hematopoietic Stem Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transplantation of Hematopoietic Stem Cells companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
CBR Systems
China Cord Blood Corporation
ViaCord
Thermo Fisher Scientific
STEMCELL Technologies
Vcanbio
Merck Millipore
Lonza Group
CellGenix Technologie Transfer
ThermoGenesis
Segment by Type
Stem Cells Storage
Stem Cells Consumables
Segment by Application
Leukemia
Lymphoproliferative Disorders
Solid Tumors
Non-Malignant Disorders
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transplantation of Hematopoietic Stem Cells companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Transplantation of Hematopoietic Stem Cells 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Stem Cells Storage
1.2.3 Stem Cells Consumables
1.3 麻豆原创 by Application
1.3.1 Global Transplantation of Hematopoietic Stem Cells 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Leukemia
1.3.3 Lymphoproliferative Disorders
1.3.4 Solid Tumors
1.3.5 Non-Malignant Disorders
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Transplantation of Hematopoietic Stem Cells 麻豆原创 Perspective (2019-2030)
2.2 Transplantation of Hematopoietic Stem Cells Growth Trends by Region
2.2.1 Global Transplantation of Hematopoietic Stem Cells 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Transplantation of Hematopoietic Stem Cells Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Transplantation of Hematopoietic Stem Cells Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Transplantation of Hematopoietic Stem Cells 麻豆原创 Dynamics
2.3.1 Transplantation of Hematopoietic Stem Cells Industry Trends
2.3.2 Transplantation of Hematopoietic Stem Cells 麻豆原创 Drivers
2.3.3 Transplantation of Hematopoietic Stem Cells 麻豆原创 Challenges
2.3.4 Transplantation of Hematopoietic Stem Cells 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transplantation of Hematopoietic Stem Cells Players by Revenue
3.1.1 Global Top Transplantation of Hematopoietic Stem Cells Players by Revenue (2019-2024)
3.1.2 Global Transplantation of Hematopoietic Stem Cells Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Transplantation of Hematopoietic Stem Cells 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Transplantation of Hematopoietic Stem Cells Revenue
3.4 Global Transplantation of Hematopoietic Stem Cells 麻豆原创 Concentration Ratio
3.4.1 Global Transplantation of Hematopoietic Stem Cells 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transplantation of Hematopoietic Stem Cells Revenue in 2023
3.5 Transplantation of Hematopoietic Stem Cells Key Players Head office and Area Served
3.6 Key Players Transplantation of Hematopoietic Stem Cells Product Solution and Service
3.7 Date of Enter into Transplantation of Hematopoietic Stem Cells 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Transplantation of Hematopoietic Stem Cells Breakdown Data by Type
4.1 Global Transplantation of Hematopoietic Stem Cells Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Transplantation of Hematopoietic Stem Cells Forecasted 麻豆原创 Size by Type (2025-2030)
5 Transplantation of Hematopoietic Stem Cells Breakdown Data by Application
5.1 Global Transplantation of Hematopoietic Stem Cells Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Transplantation of Hematopoietic Stem Cells Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Transplantation of Hematopoietic Stem Cells 麻豆原创 Size (2019-2030)
6.2 North America Transplantation of Hematopoietic Stem Cells 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Transplantation of Hematopoietic Stem Cells 麻豆原创 Size by Country (2019-2024)
6.4 North America Transplantation of Hematopoietic Stem Cells 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Transplantation of Hematopoietic Stem Cells 麻豆原创 Size (2019-2030)
7.2 Europe Transplantation of Hematopoietic Stem Cells 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Transplantation of Hematopoietic Stem Cells 麻豆原创 Size by Country (2019-2024)
7.4 Europe Transplantation of Hematopoietic Stem Cells 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Transplantation of Hematopoietic Stem Cells 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Transplantation of Hematopoietic Stem Cells 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Transplantation of Hematopoietic Stem Cells 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Transplantation of Hematopoietic Stem Cells 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Transplantation of Hematopoietic Stem Cells 麻豆原创 Size (2019-2030)
9.2 Latin America Transplantation of Hematopoietic Stem Cells 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Transplantation of Hematopoietic Stem Cells 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Transplantation of Hematopoietic Stem Cells 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transplantation of Hematopoietic Stem Cells 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Transplantation of Hematopoietic Stem Cells 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Transplantation of Hematopoietic Stem Cells 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Transplantation of Hematopoietic Stem Cells 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CBR Systems
11.1.1 CBR Systems Company Detail
11.1.2 CBR Systems Business Overview
11.1.3 CBR Systems Transplantation of Hematopoietic Stem Cells Introduction
11.1.4 CBR Systems Revenue in Transplantation of Hematopoietic Stem Cells Business (2019-2024)
11.1.5 CBR Systems Recent Development
11.2 China Cord Blood Corporation
11.2.1 China Cord Blood Corporation Company Detail
11.2.2 China Cord Blood Corporation Business Overview
11.2.3 China Cord Blood Corporation Transplantation of Hematopoietic Stem Cells Introduction
11.2.4 China Cord Blood Corporation Revenue in Transplantation of Hematopoietic Stem Cells Business (2019-2024)
11.2.5 China Cord Blood Corporation Recent Development
11.3 ViaCord
11.3.1 ViaCord Company Detail
11.3.2 ViaCord Business Overview
11.3.3 ViaCord Transplantation of Hematopoietic Stem Cells Introduction
11.3.4 ViaCord Revenue in Transplantation of Hematopoietic Stem Cells Business (2019-2024)
11.3.5 ViaCord Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Transplantation of Hematopoietic Stem Cells Introduction
11.4.4 Thermo Fisher Scientific Revenue in Transplantation of Hematopoietic Stem Cells Business (2019-2024)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 STEMCELL Technologies
11.5.1 STEMCELL Technologies Company Detail
11.5.2 STEMCELL Technologies Business Overview
11.5.3 STEMCELL Technologies Transplantation of Hematopoietic Stem Cells Introduction
11.5.4 STEMCELL Technologies Revenue in Transplantation of Hematopoietic Stem Cells Business (2019-2024)
11.5.5 STEMCELL Technologies Recent Development
11.6 Vcanbio
11.6.1 Vcanbio Company Detail
11.6.2 Vcanbio Business Overview
11.6.3 Vcanbio Transplantation of Hematopoietic Stem Cells Introduction
11.6.4 Vcanbio Revenue in Transplantation of Hematopoietic Stem Cells Business (2019-2024)
11.6.5 Vcanbio Recent Development
11.7 Merck Millipore
11.7.1 Merck Millipore Company Detail
11.7.2 Merck Millipore Business Overview
11.7.3 Merck Millipore Transplantation of Hematopoietic Stem Cells Introduction
11.7.4 Merck Millipore Revenue in Transplantation of Hematopoietic Stem Cells Business (2019-2024)
11.7.5 Merck Millipore Recent Development
11.8 Lonza Group
11.8.1 Lonza Group Company Detail
11.8.2 Lonza Group Business Overview
11.8.3 Lonza Group Transplantation of Hematopoietic Stem Cells Introduction
11.8.4 Lonza Group Revenue in Transplantation of Hematopoietic Stem Cells Business (2019-2024)
11.8.5 Lonza Group Recent Development
11.9 CellGenix Technologie Transfer
11.9.1 CellGenix Technologie Transfer Company Detail
11.9.2 CellGenix Technologie Transfer Business Overview
11.9.3 CellGenix Technologie Transfer Transplantation of Hematopoietic Stem Cells Introduction
11.9.4 CellGenix Technologie Transfer Revenue in Transplantation of Hematopoietic Stem Cells Business (2019-2024)
11.9.5 CellGenix Technologie Transfer Recent Development
11.10 ThermoGenesis
11.10.1 ThermoGenesis Company Detail
11.10.2 ThermoGenesis Business Overview
11.10.3 ThermoGenesis Transplantation of Hematopoietic Stem Cells Introduction
11.10.4 ThermoGenesis Revenue in Transplantation of Hematopoietic Stem Cells Business (2019-2024)
11.10.5 ThermoGenesis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

CBR Systems
China Cord Blood Corporation
ViaCord
Thermo Fisher Scientific
STEMCELL Technologies
Vcanbio
Merck Millipore
Lonza Group
CellGenix Technologie Transfer
ThermoGenesis

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.